Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1RA in Diabetes Mellitus Management in Children With Transfusion-Dependent Thalassemia
NCT07370922Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dulaglutide biosimilar 14028 injection in diabetes mellitus (DM), sponsored by Ain Shams University. Started Nov 2024; status: completed.
02
Drugs
dulaglutide biosimilar 14028 injection
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07370922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07370922.